These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22543122)

  • 1. [Effect of clopidogrel combined with calcium-channel blocker on coronary artery disease in elderly patients: a propensity score-based retrospective cohort study].
    Gao Y; Lu X; Cao J; Liu X; Ma C; Fan L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):462-6. PubMed ID: 22543122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison on the effects of clopidogrel, statins combination in treating coronary artery disease among the elderly patients: a retrospective cohort study].
    Gao Y; Cao J; Lu XC; Liu XF; Ma C; Fan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):337-41. PubMed ID: 22613391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
    Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
    Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting.
    Sarafoff N; Neumann L; Morath T; Bernlochner I; Mehilli J; Schömig A; Kastrati A; Sibbing D
    Am Heart J; 2011 Mar; 161(3):605-10. PubMed ID: 21392618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
    Siller-Matula JM; Lang I; Christ G; Jilma B
    J Am Coll Cardiol; 2008 Nov; 52(19):1557-63. PubMed ID: 19007592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up.
    Jeong HS; Lim HS; Park HJ; Lee WS; Choi JO; Lee HS; Jo SH; Hong SJ
    Sci Rep; 2021 Jan; 11(1):1783. PubMed ID: 33469103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
    Gremmel T; Durstberger M; Eichelberger B; Koppensteiner R; Panzer S
    Cardiovasc Ther; 2015 Oct; 33(5):264-9. PubMed ID: 26014752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Calcium-Channel Blocker Therapy on Radial Artery Grafts After Coronary Bypass Surgery.
    Gaudino M; Benedetto U; Fremes SE; Hare DL; Hayward P; Moat N; Moscarelli M; Di Franco A; Nasso G; Peric M; Petrovic I; Puskas JD; Speziale G; Yoo KJ; Girardi LN; Taggart DP;
    J Am Coll Cardiol; 2019 May; 73(18):2299-2306. PubMed ID: 31072574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Good CW; Steinhubl SR; Brennan DM; Lincoff AM; Topol EJ; Berger PB
    Circ Cardiovasc Interv; 2012 Feb; 5(1):77-81. PubMed ID: 22319066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of clopidogrel in medically managed patients with unstable angina and non-ST-segment elevation myocardial infarction.
    Solomon MD; Go AS; Shilane D; Boothroyd DB; Leong TK; Kazi DS; Chang TI; Hlatky MA
    J Am Coll Cardiol; 2014 Jun; 63(21):2249-57. PubMed ID: 24703914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis.
    Li JL; Fu Y; Qin SB; Liang GK; Liu J; Nie XY; Chen J; Shi LW; Shao H; Lu Y
    Gene; 2018 May; 657():69-80. PubMed ID: 29510176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.
    Wang CY; Lin ZF; Lee CM; Tsai YW; Huang TY; Shen LJ; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):229-238. PubMed ID: 28067454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    Heart; 2010 Feb; 96(3):186-9. PubMed ID: 19687016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Dasbiswas A; Rao MS; Babu PR; Vijayvergiya R; Nayak R; Dani S; Tyagi S; Hiremath S; Patel T; Alexander T; Prakash VS; Singh DP; Yadav MK; Pathak K; Srivastava A
    J Assoc Physicians India; 2013 Feb; 61(2):114-6, 126. PubMed ID: 24471250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical synergy of perindopril and calcium-channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study.
    Bertrand ME; Ferrari R; Remme WJ; Simoons ML; Deckers JW; Fox KM;
    Am Heart J; 2010 May; 159(5):795-802. PubMed ID: 20435188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
    Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.